Synthesis And In Vitro Evaluation of Radiolabeled Quercetin-Loaded Polymeric Nanoparticles
Project no. 32843 · Status: Kapanmış (Yayın bekleniyor) · 2025
Summary
<p>Breast cancer is the leading cause of cancer mortality among women worldwide. While numerous treatment options exist, the development of drug delivery systems is crucial due to the high toxicity of these treatments to healthy tissues. Nanotechnology based drug delivery systems, particularly PLGA (polylactic-co-glycolic acid) polymeric nanoparticles, stand out due to their biocompatibility and biodegradability. Quercetin, a molecule with limited bioavailability, is a component with potential effects on cancer cells. </p><p>In this thesis, quercetin loaded PLGA nanoparticles were synthesized and radiolabeled with Tc-99m. The nanoparticles were synthesized using a single emulsion solvent evaporation method. Characterization studies of the nanoparticles were performed using Dynamic Light Scattering (DLS), Zeta Potential, Scanning Electron Microscopy (SEM) and Energy Dispersive X-ray Fluorescence Spectrometry (EDX) analyses. Tc-99m radiolabeling of quercetin loaded PLGA nanoparticles was carried out by the SnCl2 reduction method. Quality control studies of radiolabeled nanoparticles were performed using thin layer radiochromatography (TLRC). </p><p>The average size of quercetin loaded PLGA nanoparticles was found to be 191 ±5 nm and polydispersity index was 0.049. SEM analysis revealed that the nanoparticles were synthesized as morphologically spherical and approximately 143 ±21 nm in size. The loading efficiency of quercetin compound onto PLGA nanoparticles was found to be 40 ± 2 %. To evaluate the drug release profile of the synthesized quercetin loaded PLGA nanoparticles, experiments were carried out at pH 4 and pH 7. After 48 hours, the drug release was 66.19% at pH 4, whereas it was 54.10% at pH 7.</p><p>The bioactivity of quercetin loaded PLGA nanoparticles was investigated in vitro on MCF-7 and MDA-MB-231 breast cancer cell lines. Cytotoxicity analyses revealed that the nanoparticles were more effective on the MCF-7 cell line. Incorporation studies have shown that radiolabeled quercetin-loaded PLGA nanoparticles with Tc-99m exhibit higher uptake than free Tc-99m in the MDA-MB-231 and MCF-7 cell lines.</p><p><strong>Keywords:</strong> Quercetin, Polymer Nanoparticles, Technetium-99m, Radiolabeling, Breast Cancer, Cell Culture, Nanotechnology</p>